» Articles » PMID: 16046380

Depressive Symptoms Predict Norepinephrine Response to a Psychological Stressor Task in Alzheimer's Caregivers

Overview
Journal Psychosom Med
Specialty Psychiatry
Date 2005 Jul 28
PMID 16046380
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Increased depressive symptoms have been associated with increased basal plasma norepinephrine (NE), and may be associated with exaggerated NE response to stress. This exaggerated response may play a role in health consequences associated with caring for a loved-one with Alzheimer's disease. The current study examined the relations between the level of depressive symptoms in spousal caregivers and the physiological response to a psychological stress task.

Methods: Fifty-five spousal caregivers (mean age 73 +/- 8 years) completed the depression subscale of the Brief Symptom Inventory (BSI). Plasma NE levels were assessed before and immediately after a speech stressor conducted at the caregiver's home. Hierarchical linear regression was used to determine whether caregiver depressive symptoms significantly improved prediction of change in NE levels beyond other factors theoretically and empirically related to NE.

Results: Level of depressive symptoms significantly predicted post-stressor change in NE levels (p < .01), even when controlling for age, caregiver distress, presence of caregiver hypertension, and care recipient level of cognitive function. Higher levels of depressive symptoms were associated with a greater plasma NE response to the psychological stress task.

Conclusions: Depressive symptoms may act to exaggerate NE response to the stress of caregiving, potentially leading to an allostatic load that might predispose caregivers to negative health consequences, including cardiovascular morbidity.

Citing Articles

Takotsubo Syndrome: Differences between Peripartum Period and General Population.

Tzerefos S, Aloizou D, Nikolakopoulou S, Aloizos S Healthcare (Basel). 2024; 12(16).

PMID: 39201162 PMC: 11354156. DOI: 10.3390/healthcare12161602.


Coronavirus Disease 2019 and Takotsubo Syndrome.

Zhou L, Chen Z, Jiang R, Hu Y, Zhu B, Yang C Rev Cardiovasc Med. 2024; 23(9):298.

PMID: 39077710 PMC: 11262341. DOI: 10.31083/j.rcm2309298.


Takotsubo Syndrome: The Secret Crosstalk between Heart and Brain.

Schino S, Bezzeccheri A, Russo A, Bonanni M, Cosma J, Sangiorgi G Rev Cardiovasc Med. 2024; 24(1):19.

PMID: 39076872 PMC: 11270389. DOI: 10.31083/j.rcm2401019.


A case of reinitiation of modified electroconvulsive therapy 2 weeks after modified electroconvulsive therapy-induced Takotsubo cardiomyopathy in a male patient with major depressive disorder.

Kezuka D, Haruyama A, Suzuki E, Sakuma K PCN Rep. 2024; 3(2):e221.

PMID: 38919546 PMC: 11199058. DOI: 10.1002/pcn5.221.


The Octopus Trap of Takotsubo and Stroke: Genetics, Biomarkers and Clinical Management.

Canavero I, Rifino N, Bussotti M, Carrozzini T, Potenza A, Gorla G J Pers Med. 2022; 12(8).

PMID: 36013193 PMC: 9410002. DOI: 10.3390/jpm12081244.